Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Athira Pharma, Inc.
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
August 01, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Association International Conference (AAIC) 2024
July 31, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Announces Last Patient Completed LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
July 09, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients
June 12, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)
June 11, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma to Participate in Upcoming June Conferences
May 29, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
May 17, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
May 15, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma to Participate in Upcoming May Conferences
May 02, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
April 15, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
April 11, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
April 03, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
March 08, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
February 22, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
February 08, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
January 08, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
January 03, 2024
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
December 12, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma to Participate in Sidoti December Small Cap Investor Conference
November 29, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND
November 28, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton’s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer’s Disease
November 15, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
November 09, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma to Participate in Jefferies London Healthcare Conference
November 08, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Presents Preclinical Data Further Supporting the Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
October 05, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma to Participate in Upcoming October Conferences
September 28, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 19, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
August 10, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Presents Phase 2 Clinical Data Correlating Improvements in Biomarkers of Neurodegeneration and Neuroinflammation with Improvements in Measures of Cognition and Function in Alzheimer’s Disease
July 17, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma Announces Upcoming Presentations at the Alzheimer’s Association International Conference (AAIC) 2023
July 06, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Athira Pharma to Participate in Upcoming June Conferences
May 31, 2023
From
Athira Pharma, Inc.
Via
GlobeNewswire
Tickers
ATHA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.